BLUEPRINT MEDICINES CORP (BPMC) Stock Analyst Ratings
NASDAQ:BPMC - Nasdaq - US09627Y1091 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 68% to BPMC. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 132.96. This target is 2.71% above the current price.
BPMC was analyzed by 25 analysts. The buy percentage consensus is at 68. So analysts seem to be have mildly positive about BPMC.
In the last month the buy percentage fell by 12 points. So the trust of analysts is decreasing.
BPMC was analyzed by 25 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-06-17 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2025-06-05 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-05 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-06-04 | Citigroup | Upgrade | Sell -> Neutral |
| 2025-06-03 | Wolfe Research | Downgrade | Outperform -> Peer Perform |
| 2025-06-03 | JMP Securities | Downgrade | Market Outperform -> Market Perform |
| 2025-06-03 | Stephens & Co. | Downgrade | Overweight -> Equal-Weight |
| 2025-06-02 | ScotiaBank | Downgrade | Sector Outperform -> Sector Perform |
| 2025-06-02 | Needham | Downgrade | Buy -> Hold |
| 2025-06-02 | Wedbush | Downgrade | Outperform -> Neutral |
| 2025-06-02 | JP Morgan | Downgrade | Overweight -> Neutral |
| 2025-05-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-04-28 | Needham | Maintains | Buy -> Buy |
| 2025-04-16 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-03-17 | Jefferies | Initiate | Buy |
| 2025-03-07 | ScotiaBank | Initiate | Sector Outperform |
| 2025-03-03 | Citizens Capital Markets | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-14 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-02-14 | Needham | Reiterate | Buy -> Buy |
| 2025-02-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-13 | Needham | Reiterate | Buy -> Buy |
| 2025-02-04 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-01-27 | Piper Sandler | Maintains | Neutral -> Neutral |
| 2025-01-15 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-01-13 | Needham | Reiterate | Buy -> Buy |
| 2025-01-13 | Wedbush | Reiterate | Outperform -> Outperform |
| 2025-01-02 | Stephens & Co. | Reiterate | Overweight -> Overweight |
| 2024-12-11 | Guggenheim | Reiterate | Buy -> Buy |
| 2024-12-09 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |